| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Toxicology, University of Tübingen, 72074 Tübingen, Germany [S. K.], and Department of Pharmacology and Molecular Toxicology, University of Massachusetts Medical Center, Worcester, Massachusetts 01655 [W. F. G.]
In this report, we present a characterization of the cell-specific expression of two human cytochrome P450 genes, CYP1A1 and CYP1B1, by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). The TCDD-dependent induction of CYP1A1 has been studied extensively and serves as the prototype response for a TCDD-signaling pathway initiated by the reversible binding of TCDD to an intracellular receptor [designated the aryl hydrocarbon (Ah) receptor]. CYP1A1 is induced by TCDD to high levels (45-fold increase) in the human hepatoblastoma line HepG2 as compared with the human renal adenocarcinoma line ACHN. In contrast, CYP1B1 is induced selectively in ACHN cells. Cell-specific induction of CYP1A1 and CYP1B1 mRNA correlates with comparable changes in the corresponding proteins and results, at least in part, from transcriptional activation. Characterization of the mechanism(s) for the differential regulation of CYP1A1 was carried out. Nuclear extracts obtained from either cell line following treatment with TCDD displayed equivalent binding to oligonucleotide probes for two dioxin-responsive elements located 5'-ward of the CYP1A1 promoter. This result obtained with broken cell fractions was confirmed by an intact cell DNA protection assay. Possible involvement of negative regulators is suggested by the presence of a negative regulatory element in the 5' flanking region of the CYP1A1 gene and the observed superinduction of CYP1A1 mRNA by cycloheximide in TCDD-treated HepG2 cells. Electromobility shift analysis using negative regulatory element probes, however, did not detect quantitative differences in the binding of nuclear extract proteins obtained from either HepG2 or ACHN cells treated with TCDD. These findings indicate that the ligand-dependent activation and dioxin-responsive element binding of the Ah receptor required for CYP1A1 induction in HepG2 cells also can occur in ACHN cells. We conclude that the repression of TCDD-dependent CYP1A1 induction in ACHN cells occurs at the level of transactivation in the Ah receptor signal transduction pathway.
1 This work was supported in part by Grant Kr1480/2-1 from the Deutsche Forschungsgemeinschaft (to S. K.) and grants from the Chemical Manufacturer's Association (to W. F. G.), General Electric Company (to W. F. G.), and USPHS Grant ES07009 (to W. F. G.).
2 To whom requests for reprints should be addressed, at Department of Pharmacology and Molecular Toxicology, University of Massachusetts Medical Center, 55 Lake Avenue North, Worcester, MA 01655. Phone: (508) 856-2151; Fax: (508) 856-5080; E-mail: william.greenlee@ummed.edu.
Received 9/23/96. Accepted 2/ 8/97.
This article has been cited by other articles:
|
|
 |
|
  J. Yu, Y. Wang, W.-H. Zhou, L. Wang, Y.-Y. He, and D.-J. Li Combination of estrogen and dioxin is involved in the pathogenesis of endometriosis by promoting chemokine secretion and invasion of endometrial stromal cells Hum. Reprod., July 1, 2008; 23(7): 1614 - 1626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Chang, H. Chang, P.-H. Chen, S.-L. Lin, and P. Lin Requirement of Aryl Hydrocarbon Receptor Overexpression for CYP1B1 Up-Regulation and Cell Growth in Human Lung Adenocarcinomas Clin. Cancer Res., January 1, 2007; 13(1): 38 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Ciolino, C. J. MacDonald, O. S. Memon, S. E. Bass, and G. C. Yeh Sulindac regulates the aryl hydrocarbon receptor-mediated expression of Phase 1 metabolic enzymes in vivo and in vitro Carcinogenesis, August 1, 2006; 27(8): 1586 - 1592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Chang, L. W. Chang, Y.-H. Cheng, W.-T. Tsai, M.-X. Tsai, and P. Lin Preferential Induction of CYP1A1 and CYP1B1 in CCSP-Positive Cells Toxicol. Sci., January 1, 2006; 89(1): 205 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-M. Yang, D.-Y. Huang, G.-F. Liu, J.-C. Zhong, K. Du, Y.-F. Li, and X.-H. Song Inhibitory Effects of Vitamin A on TCDD-induced Cytochrome P-450 1A1 Enzyme Activity and Expression Toxicol. Sci., May 1, 2005; 85(1): 727 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Joiakim, P. A. Mathieu, A. A. Elliott, and J. J. Reiners Jr. Superinduction of CYP1A1 in MCF10A Cultures by Cycloheximide, Anisomycin, and Puromycin: A Process Independent of Effects on Protein Translation and Unrelated to Suppression of Aryl Hydrocarbon Receptor Proteolysis by the Proteasome Mol. Pharmacol., October 1, 2004; 66(4): 936 - 947. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Anttila, J. Hakkola, P. Tuominen, E. Elovaara, K. Husgafvel-Pursiainen, A. Karjalainen, A. Hirvonen, and T. Nurminen Methylation of Cytochrome P4501A1 Promoter in the Lung Is Associated with Tobacco Smoking Cancer Res., December 15, 2003; 63(24): 8623 - 8628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Pinpin Lin, Han Chang, W.-T. Tsai, M.-H. Wu, Y.-S. Liao, J.-T. Chen, and J.-M. Su Overexpression of Aryl Hydrocarbon Receptor in Human Lung Carcinomas Toxicol Pathol, January 1, 2003; 31(1): 22 - 30. [Abstract] [PDF]
|
|
|
|
|
|
B. Husbeck and G. Powis The redox protein thioredoxin-1 regulates the constitutive and inducible expression of the estrogen metabolizing cytochromes P450 1B1 and 1A1 in MCF-7 human breast cancer cells Carcinogenesis, October 1, 2002; 23(10): 1625 - 1630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Spink, B. H. Katz, M. M. Hussain, B. C. Spink, S. J. Wu, N. Liu, R. Pause, and L. S. Kaminsky Induction of CYP1A1 and CYP1B1 in T-47D Human Breast Cancer Cells by Benzo[a]pyrene Is Diminished by Arsenite Drug Metab. Dispos., March 1, 2002; 30(3): 262 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Larsen-Su and D. E. Williams Transplacental Exposure to Indole-3-carbinol Induces Sex-Specific Expression of CYP1A1 and CYP1B1 in the Liver of Fischer 344 Neonatal Rats Toxicol. Sci., December 1, 2001; 64(2): 162 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-W. Wang, T.-L. Chen, P.-C. Yang, and T.-H. Ueng Induction of Cytochromes P450 1A1 and 1B1 by Emodin in Human Lung Adenocarcinoma Cell Line CL5 Drug Metab. Dispos., September 1, 2001; 29(9): 1229 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Pitt, L. Feng, B. D. Abbott, J. Schmid, R. E. Batt, T. G. Costich, S. T. Koury, and D. P. Bofinger Expression of AhR and ARNT mRNA in Cultured Human Endometrial Explants Exposed to TCDD Toxicol. Sci., August 1, 2001; 62(2): 289 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Dahl and R. T. Mulcahy Cell-Type Specific Differences in Glutamate Cysteine Ligase Transcriptional Regulation Demonstrate Independent Subunit Control Toxicol. Sci., June 1, 2001; 61(2): 265 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-S. Chua, E. Kashiyama, T. D. Bradshaw, S. F. Stinson, E. Brantley, E. A. Sausville, and M. F. G. Stevens Role of CYP1A1 in Modulation of Antitumor Properties of the Novel Agent 2-(4-Amino-3-methylphenyl)benzothiazole (DF 203, NSC 674495) in Human Breast Cancer Cells Cancer Res., September 1, 2000; 60(18): 5196 - 5203. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. E. Shehin, R. O. Stephenson, and W. F. Greenlee Transcriptional Regulation of the Human CYP1B1 Gene. EVIDENCE FOR INVOLVEMENT OF AN ARYL HYDROCARBON RECEPTOR RESPONSE ELEMENT IN CONSTITUTIVE EXPRESSION J. Biol. Chem., March 15, 2000; 275(10): 6770 - 6776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Ciolino and G. C. Yeh Inhibition of Aryl Hydrocarbon-Induced Cytochrome P-450 1A1 Enzyme Activity and CYP1A1 Expression by Resveratrol Mol. Pharmacol., October 1, 1999; 56(4): 760 - 767. [Abstract] [Full Text]
|
|
|
|
|
|
Y. M. Tang, G.-F. Chen, P. A. Thompson, D.-X. Lin, N. P. Lang, and F. F. Kadlubar Development of an AntiPeptide Antibody That Binds to the C-Terminal Region of Human CYP1B1 Drug Metab. Dispos., February 1, 1999; 27(2): 274 - 280. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Heidel, C. J. Czuprynski, and C. R. Jefcoate Bone Marrow Stromal Cells Constitutively Express High Levels of Cytochrome P4501B1 that Metabolize 7,12-Dimethylbenz[a]anthracene Mol. Pharmacol., December 1, 1998; 54(6): 1000 - 1006. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
